Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib

NCT01459757 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 322

Last updated 2013-06-19

No results posted yet for this study

Summary

Retrospective correlation of clinical outcomes data with mutational status in GIST subjects treated with sunitinib.

Conditions

Interventions

OTHER

non-interventional

Non-interventional; Mutational status data analyzed previously but not collected in the A6181036 study, will be correlated wth A6181036 clinical outcomes data collected during the A6181036 study.

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • United States
  • Australia
  • Belgium
  • Canada
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Netherlands
  • Poland
  • Slovakia
  • South Korea
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01459757 on ClinicalTrials.gov